Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Albumin (as Excipient) Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Albumin (as Excipient) Market Status and Forecast (2016-2027)
      • 1.3.2 Global Albumin (as Excipient) Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Albumin (as Excipient) Supply by Company

    • 2.1 Global Albumin (as Excipient) Sales Volume by Company
    • 2.2 Global Albumin (as Excipient) Sales Value by Company
    • 2.3 Global Albumin (as Excipient) Price by Company
    • 2.4 Albumin (as Excipient) Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Albumin (as Excipient) Market Status by Category

    • 3.1 Albumin (as Excipient) Category Introduction
      • 3.1.1 Human Serum Albumin
      • 3.1.2 Recombinant Albumin
    • 3.2 Global Albumin (as Excipient) Market by Category
      • 3.2.1 Global Albumin (as Excipient) Sales Volume by Category (2016-2021)
      • 3.2.2 Global Albumin (as Excipient) Sales Value by Category (2016-2021)
      • 3.2.3 Global Albumin (as Excipient) Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Albumin (as Excipient) Market Status by End User/Segment

    • 4.1 Albumin (as Excipient) Segment by End User/Segment
      • 4.1.1 Cell Culture Media
      • 4.1.2 Medical Supplements
      • 4.1.3 Therapeutics
    • 4.2 Global Albumin (as Excipient) Market by End User/Segment
      • 4.2.1 Global Albumin (as Excipient) Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Albumin (as Excipient) Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Albumin (as Excipient) Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Albumin (as Excipient) Market Status by Region

    • 5.1 Global Albumin (as Excipient) Market by Region
      • 5.1.1 Global Albumin (as Excipient) Sales Volume by Region
      • 5.1.2 Global Albumin (as Excipient) Sales Value by Region
    • 5.2 North America Albumin (as Excipient) Market Status
    • 5.3 Europe Albumin (as Excipient) Market Status
    • 5.4 Asia Pacific Albumin (as Excipient) Market Status
    • 5.5 Central & South America Albumin (as Excipient) Market Status
    • 5.6 Middle East & Africa Albumin (as Excipient) Market Status

    6 North America Albumin (as Excipient) Market Status

    • 6.1 North America Albumin (as Excipient) Market by Country
      • 6.1.1 North America Albumin (as Excipient) Sales Volume by Country (2016-2021)
      • 6.1.2 North America Albumin (as Excipient) Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Albumin (as Excipient) Market Status

    • 7.1 Europe Albumin (as Excipient) Market by Country
      • 7.1.1 Europe Albumin (as Excipient) Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Albumin (as Excipient) Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Albumin (as Excipient) Market Status

    • 8.1 Asia Pacific Albumin (as Excipient) Market by Country
      • 8.1.1 Asia Pacific Albumin (as Excipient) Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Albumin (as Excipient) Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Albumin (as Excipient) Market Status

    • 9.1 Central & South America Albumin (as Excipient) Market by Country
      • 9.1.1 Central & South America Albumin (as Excipient) Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Albumin (as Excipient) Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Albumin (as Excipient) Market Status

    • 10.1 Middle East & Africa Albumin (as Excipient) Market by Country
      • 10.1.1 Middle East & Africa Albumin (as Excipient) Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Albumin (as Excipient) Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Albumin (as Excipient) Distributors
    • 11.3 Albumin (as Excipient) Buyers

    12 Global Albumin (as Excipient) Market Forecast by Category and by End User/Segment

    • 12.1 Global Albumin (as Excipient) Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Albumin (as Excipient) Forecast by Category
      • 12.2.1 Global Albumin (as Excipient) Sales Volume Forecast by Category
      • 12.2.2 Global Albumin (as Excipient) Sales Value Forecast by Category
      • 12.2.3 Global Albumin (as Excipient) Price Forecast by Category
    • 12.3 Global Albumin (as Excipient) Forecast by End User/Segment
      • 12.3.1 Global Albumin (as Excipient) Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Albumin (as Excipient) Sales Value Forecast by End User/Segment
      • 12.3.3 Global Albumin (as Excipient) Price Forecast by End User/Segment

    13 Global Albumin (as Excipient) Market Forecast by Region/Country

    • 13.1 Global Albumin (as Excipient) Market Forecast by Region (2022-2027)
      • 13.1.1 Global Albumin (as Excipient) Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Albumin (as Excipient) Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 CSL
      • 14.1.1 Company Information
      • 14.1.2 Albumin (as Excipient) Product Introduction
      • 14.1.3 CSL Albumin (as Excipient) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Grifols
      • 14.2.1 Company Information
      • 14.2.2 Albumin (as Excipient) Product Introduction
      • 14.2.3 Grifols Albumin (as Excipient) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Ventria (InVitria)
      • 14.3.1 Company Information
      • 14.3.2 Albumin (as Excipient) Product Introduction
      • 14.3.3 Ventria (InVitria) Albumin (as Excipient) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Hualan Bio
      • 14.4.1 Company Information
      • 14.4.2 Albumin (as Excipient) Product Introduction
      • 14.4.3 Hualan Bio Albumin (as Excipient) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 HiMedia
      • 14.5.1 Company Information
      • 14.5.2 Albumin (as Excipient) Product Introduction
      • 14.5.3 HiMedia Albumin (as Excipient) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Biotest
      • 14.6.1 Company Information
      • 14.6.2 Albumin (as Excipient) Product Introduction
      • 14.6.3 Biotest Albumin (as Excipient) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 CBPO
      • 14.7.1 Company Information
      • 14.7.2 Albumin (as Excipient) Product Introduction
      • 14.7.3 CBPO Albumin (as Excipient) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Octapharma
      • 14.8.1 Company Information
      • 14.8.2 Albumin (as Excipient) Product Introduction
      • 14.8.3 Octapharma Albumin (as Excipient) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Shanghai RAAS
      • 14.9.1 Company Information
      • 14.9.2 Albumin (as Excipient) Product Introduction
      • 14.9.3 Shanghai RAAS Albumin (as Excipient) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Albumedix
      • 14.10.1 Company Information
      • 14.10.2 Albumin (as Excipient) Product Introduction
      • 14.10.3 Albumedix Albumin (as Excipient) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Kedrion
    • 14.12 Merck
    • 14.13 LFB Group
    • 14.14 Takeda

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Albumin (as Excipient) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Albumin (as Excipient) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Human Serum Albumin
    Recombinant Albumin

    Segmented by End User/Segment
    Cell Culture Media
    Medical Supplements
    Therapeutics

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    CSL
    Grifols
    Ventria (InVitria)
    Hualan Bio
    HiMedia
    Biotest
    CBPO
    Octapharma
    Shanghai RAAS
    Albumedix
    Kedrion
    Merck
    LFB Group
    Takeda
    Buy now